l*****o
发帖数: 473 | 1 各位专家前辈好。
朋友小孩3岁，发现神经母细胞瘤4期了。http://baike.baidu.com/view/825067.htm#3
这种情况不知道治疗的希望大吗？有没有最新的药物？在美国那家医院的专家好点？
另外，不知道是否有Clinic Trial的？有没有人了解这方面的知识？ |
l*****o
发帖数: 473 | |
H******9
发帖数: 8087 | |
l*****o
发帖数: 473 | |
l*h
发帖数: 4124 | 5 currently the most useful outcome indicator is risk stratification. low and
intermediate risk groups have fairly good outcomes. but high risk group have
very poor outcome. basically all treatment for high risk group is
experimental. so far as i know, MSKCC has the best treatment results for
high risk group because they developed two good antibodies for this disease.
【在 l*****o 的大作中提到】
: 各位专家前辈好。
: 朋友小孩3岁，发现神经母细胞瘤4期了。http://baike.baidu.com/view/825067.htm#3
: 这种情况不知道治疗的希望大吗？有没有最新的药物？在美国那家医院的专家好点？
: 另外，不知道是否有Clinic Trial的？有没有人了解这方面的知识？
|
l*****o
发帖数: 473 | 6 非常非常感谢。
好像很多朋友都指出了MSKCC is the best.
Thanks very much!
and
have
disease.
【在 l*h 的大作中提到】
: currently the most useful outcome indicator is risk stratification. low and
: intermediate risk groups have fairly good outcomes. but high risk group have
: very poor outcome. basically all treatment for high risk group is
: experimental. so far as i know, MSKCC has the best treatment results for
: high risk group because they developed two good antibodies for this disease.
|
